For Laboratorios
Clausen SA it is essential to ensure
that we provide safe, effective
and high quality drugs, reason why,
it is important to promote an institutional
pharmacovigilance program. To accomplish
this goal, we have created a multidisciplinary
Department where physicians and
pharmaceutics chemists work together.
The commitment with our products
does not end when they are marketed,
but is rather a continuous and permanent
effort.
What is pharmacovigilance?
Pharmacovigilance is concerned with
the identification, assessment and
prevention of risks associated with
drugs once marketed.
Its main objectives are:
1. Early detection of adverse reactions and
interactions so far unknown.
2. The detection of increased frequency of adverse
reactions (known).
3. The estimate of the quantitative aspects
of risk/benefit ratio and the diffusion
of needed information to improve
the regulation and
prescription drugs.
In order to continue to improve
we have created a space to send
us any questions you may have about
our products. The members of the
Pharmacovigilance Department will
answer you.
The information you send is confidential.
References: Uppsala Monitoring Centre,
World Health Organization
 |
